Wall Street Journal
Commercial News
3/2/21
WSJ.com: US Business
Target Keeps Growing at Rivals' Expense
The retailer?s holiday sales rose solidly, capping off a year when revenue increased more than it had in the previous 11 years combined.
Kohl's Is 'Way Ahead' of Activist Investors, CEO Says
The retail chain said it would restart share buybacks and dividends and spend at least $550 million on capital expenditures during new fiscal year.
Puff Bar Defies Fruity E-Cigarette Crackdown
In an effort to sidestep FDA rules on fruity, disposable vaporizers, e-cigarette brand Puff Bar says it is using nicotine that isn?t derived from tobacco.
Merck to Help Johnson & Johnson Make Its Covid-19 Vaccine
The assistance from a competitor, to be announced by President Biden on Tuesday, will help speed up production of the recently approved single-shot vaccine.
CVS, Walgreens Look for Big Data Reward From Covid-19 Vaccines
Chains are collecting data from millions of customers as they sign up for shots, enrolling them in patient systems and having recipients register customer profiles.
Senate Democrats Iron Out Details on Covid-19 Aid Package
Senate Democrats sought to bridge differences over jobless benefits, aid for state and local governments and $1,400 direct payments as they aim to complete a $1.9 trillion coronavirus relief package and pass it through their chamber in the coming days.
Is Inflation a Risk? Not Now, but Some See Danger Ahead
Though slack in the economy and a vigilant Fed currently keep prices well in check, some influential economists say political pressure and a new emphasis on maximizing employment could test the central bank?s resolve to raise rates by enough when inflation risks emerge.